Solid Tumor
Showing NaN - NaN of 49
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
-
Duarte, California
- +26 more
Nov 2, 2021
Subjects Treated With ACTR T Cell Product
Terminated
- B Cell Lymphomas
- +3 more
- ACTR T Cell Product
-
Gilbert, Arizona
- +15 more
Oct 4, 2021
Solid Tumor Trial in Boston (Prexasertib, Olaparib)
Completed
- Solid Tumor
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 1, 2021
Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)
Recruiting
- Solid Tumor
- +2 more
- T3011
- T3011 + pembrolizumab
-
Gilbert, Arizona
- +7 more
Jun 22, 2021
Solid Tumor, Solid Tumor Trial in Worldwide (BEZ235 + MEK162)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- Solid Tumor
- BEZ235 + MEK162
-
Boston, Massachusetts
- +5 more
Oct 7, 2020
Solid Tumor, Kidney Cancer Trial in Boston (pazopanib, everolimus)
Completed
- Solid Tumor
- Kidney Cancer
-
Boston, Massachusetts
- +1 more
Sep 18, 2019
Solid Tumor, Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations, Tenosynovial Giant Cell Tumor
Terminated
- Solid Tumor
- +2 more
- PLX7486 TsOH
-
Los Angeles, California
- +3 more
Aug 1, 2018
Solid Tumor, Liver Metastases Trial in Boston (Stereotactic body radiotherapy-proton)
Completed
- Solid Tumor
- Liver Metastases
- Stereotactic body radiotherapy-proton
-
Boston, Massachusetts
- +1 more
Oct 3, 2017
Solid Tumor Trial in Boston (BAY 1000394)
Withdrawn
- Solid Tumor
- BAY 1000394
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 29, 2016
Sarcoma, Solid Tumor Trial in Boston (RAD001, CP-751,871)
Completed
- Sarcoma
- Solid Tumor
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 12, 2013